# Trade Mark Journal No.2025/051 19 December 2025

## WO0000001877241 (5,10,42)

Office of origin: United States of America

Date of International Registration:21 August 2025
Date of designation in the UK: 21 August 2025

International priority date claimed: 21 February 2025 (United States of America) (99050567)

Class 5
  Pharmaceutical preparations for the treatment of solid tumors; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of neurogenerative diseases; pharmaceutical preparations for the treatment of chronic inflammatory diseases; vaccines; therapeutic vaccines; therapeutic vaccines for solid tumors; diagnostic kits comprising diagnostic agents, preparations and substances for medical use.
Class 10
  Medical devices for use in treating solid tumors; medical devices for diagnosis of solid tumors and matching liquid biopsy.
Class 42
  Vaccine research and development; research and development of pharmaceuticals for solid tumors.

Tidewave Biotech, Inc.

Representative: Alexis Crawford Douglas K&L Gates LLP, P.O. BOX 1135, Chicago IL 60690-1135, UNITED STATES OF AMERICA